Diabetic type 2. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: control group: Placebo tablet. Intervention 2: Intervention: Group1: Patients With 15 mg per Day Of saffron. Group 2: Patients With 15 mg per Day Of Crocin.
Treatment - Drugs
control group: Placebo tablet.
Intervention: Group1: Patients With 15 mg per Day Of saffron. Group 2: Patients With 15 mg per Day Of Crocin
Sponsors
Mashhad University of Medical Science
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Adult patients (18 =) with type 1 and 2 diabetes? Patients with uncontrolled type 2 diabetes mellitus, and HbA1c> 7-7.5? Patients who have the ability to understand overview of the study, treatment and possible side effects?Filling the consent form. Exclusion criteria: Patients suffering from CKD, and Liver disease, and patients with pregnancy and breast-feeding?Incidence of any side effects in which the patient cannot continue to study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar. Timepoint: every week. Method of measurement: glucometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1C. Timepoint: Before intervention,and three months later. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Seyed Ahmad Mohajeri
Mashhad University of Medical Sciences
Outcome results
None listed